<DOC>
	<DOCNO>NCT00415610</DOCNO>
	<brief_summary>The purpose trial evaluate safety effectiveness lower blood pressure use nicardipine person acute hypertension associate intracerebral hemorrhage .</brief_summary>
	<brief_title>Antihypertensive Treatment Acute Cerebral Hemorrhage</brief_title>
	<detailed_description>An estimate 37,000 52,400 people United States intracerebral hemorrhage ( ICH ) every year . ICH——a form stroke poor outcome difficult treat——is associate high mortality rate stroke . Hematoma expansion identify common cause neurological deterioration person ICH . Early evidence suggest acute hypertension ( HTN ) —or elevate blood pressure—may make individual susceptible hematoma expansion . Treating HTN acutely may prevent hematoma expansion , however , effect aggressive HTN treatment determine . The purpose trial evaluate treatment feasibility safety lower blood pressure use nicardipine——an antihypertensive medication——in person acute HTN associate ICH . This pilot study enroll 60 individual qualify present systolic blood pressure least 170 mmHg , ICH , evaluate treatment initiate within 6 hour onset stroke symptom . In stepwise fashion , scientist investigate potential consequence control blood pressure intravenous nicardipine 3 sequential level : 170 200 mmHg , 140 170 mmHg , 110 140 mmHg . Twenty participant enrol per level . Treatment last 18 24 hour . Participants stay hospital 7 day ( include 24 hour intensive care unit close monitoring ) return 1-hour follow-up visit 30 day 90 day discharge hospital . During visit participant receive neurological assessment determine functional outcome . For participant , study complete 90-day follow-up visit .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Nicardipine</mesh_term>
	<criteria>Age old 18 year . Onset new neurological sign stroke within 12 hour time evaluation AND initiation treatment intravenous nicardipine . Clinical sign consistent diagnosis stroke , include impairment language , motor function , cognition , and/or gaze , vision , neglect . The total GCS score great 8 time enrollment . CT scan demonstrates intraparenchymal hematoma manual hematoma volume measurement le 60 cc . ICH supratentorial locate lobar , basal ganglionic , thalamic base initial CT scan appearance . Admission systolic blood pressure great 170 mm Hg two repeat measurement least 5 minute apart . Evidence chronic hypertension . Subject consider surgical candidate neurosurgery service . Time symptom onset reliably assess . Previously know neoplasm , arteriovenous malformation , aneurysms . Intracerebral hematoma consider related trauma neurologist neurosurgeon . ICH locate cortex infratentorial region pons cerebellum . Blood visualize subarachnoid space . Intravenous nicardipine initiate within 12 hour symptom onset . Use clonidine hydrochloride central alphaagonist within last 48 hour potential withdrawal hypertension . Pregnancy , lactation , parturition within previous 30 day . Any history bleeding diathesis coagulopathy , include use warfarin . Use heparin previous 48 hour prolong partial thromboplastin time . Known atrialventricular heart block first degree , sick sinus syndrome without pacemaker . Intolerance calcium channel blocker . Exposure study medication precede 24 hour prior enrollment . A platelet count less 100 000/mm3 . Major surgery within previous six week . History intracranial hemorrhage ( include intracerebral subarachnoid hemorrhage ) hemorrhagic stroke . Seizure onset stroke . Blood glucose less 50 mg/dL great 400 mg/dL . Current participation another research drug treatment protocol . Isolated ventricular blood CT scan . Subject living precludes aggressive intensive care unit management . Subject acute myocardial infarction renal failure precludes use aggressive antihypertensive therapy . Subjects unstable angina acute myocardial infarction within 2 week prior ICH . Subjects renal insufficiency serum creatinine great 2.0 mg/dl renal dialysis . Sinus tachycardia exceed 120 beat per minute supraventricular tachycardia observe initial evaluation . Ischemic stroke within 4 week presentation . Congestive heart failure grade class III IV New York Heart Association ( NYHA ) classification .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>cerebral hemorrhage</keyword>
	<keyword>intracerebral hemorrhage</keyword>
	<keyword>stroke</keyword>
	<keyword>hypertension</keyword>
	<keyword>blood pressure</keyword>
	<keyword>nicardipine</keyword>
	<keyword>antihypertensive agent</keyword>
	<keyword>hematoma expansion</keyword>
</DOC>